PE 22-28 peptide – anyone seen human data yet?
Posted by student748 in Research & News - 34 points, 4 comments.
Just came across the entry for PE 22-28 on the peptides database – it’s a spadin‑derived TREK-1 blocker that’s shown fast antidepressant effects in animal models by boosting neurogenesis and synaptogenesis. For what it is worth, the preclinical stuff looks pretty neat but the page says no established human dose, unknown safety and no approved use yet. I’m keen to hear if anyone’s stumbled across a small human trial or a case report i missed.
Seems like the kind of compound that could be interesting for mood or recovery work, but i’d want to see some basic toxicity data before even thinking about trying it. What do you think – is this one worth watching closely or just another preclinical curiosity? Drop any links or thoughts if you’ve got them.
Comments
- early_chemist: I reckon it is still in the preclinical curiosity stage. I have been looking into spadin derivatives myself lately, but I have not found a single peer reviewed human trial for PE 22-28 specifically. The mechanism of blocking TREK-1 channels to encourage new synapse growth sounds brilliant on paper (and the animal data is quite compelling), but the safety profile is a complete unknown. Anecdotally, I have found that compounds targeting specific ion channels can sometimes lead to unpredictable ne
- nof1184: I agree, it sounds too risky now. Anecdotally, I always worry about these neurological effects when I read about ion channels, I do not understand them well. Is there a safer peptide for mood that is more common, maybe something with more human data?
- experiment_diego: I agree with you on the safety side. Those ion channel effects make me quite nervous if we do not have a CLEAR toxicity report first. Since I am new to these types of peptides, do you know if there are any similar compounds that actually have human data? I would be keen to see if something else is already proven safe 🕰️.
- student748: Yeah the ion channel stuff definitely gives me pause too, haven't seen a proper toxicity report anywhere yet. Appreciate you flagging that. Been scanning through the spadin derivatives and most the human data is still at the cell line stage. Curious if you've come across anything with even a small pilot study? Always down to look at what's actually been tested in people rather than just animal work. Would love to hear what you've seen if anything's crossed your bench.
Community discussion - research and educational context only. Not medical advice.